Seeking Alpha

Regulus Therapeutics misses by $0.06, beats on revenues

  • Regulus Therapeutics (RGLS): Q2 EPS of -$0.20 misses by $0.06.
  • Revenue of $4.76M beats by $1.32M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector